175 related articles for article (PubMed ID: 33244871)
1. Decreased plasma n6 : n3 polyunsaturated fatty acids ratio interacting with high C-peptide promotes non-alcoholic fatty liver disease in type 2 diabetes patients.
Luo HH; Zhao MD; Feng XF; Gao XQ; Hong M; Liu ML; Li YP; Liu WQ; Liu YM; Yu CC; Cao YF; Yang XL; Fang ZZ; Zhang P
J Diabetes Investig; 2021 Jul; 12(7):1263-1271. PubMed ID: 33244871
[TBL] [Abstract][Full Text] [Related]
2. Serum phospholipid omega-3 polyunsaturated fatty acids and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease.
Lou DJ; Zhu QQ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ
J Diabetes Complications; 2014; 28(5):711-4. PubMed ID: 24927647
[TBL] [Abstract][Full Text] [Related]
3. Association of Dietary n3 and n6 Fatty Acids Intake with Hypertension: NHANES 2007-2014.
Chen J; Sun B; Zhang D
Nutrients; 2019 May; 11(6):. PubMed ID: 31151215
[TBL] [Abstract][Full Text] [Related]
4. Long-chain saturated fatty acids and its interaction with insulin resistance and the risk of nonalcoholic fatty liver disease in type 2 diabetes in Chinese.
Jiang LP; Sun HZ
Front Endocrinol (Lausanne); 2022; 13():1051807. PubMed ID: 36568120
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study.
Chen ZY; Liu M; Jing LP; Xiao ML; Dong HL; Chen GD; Chen YM
Eur J Nutr; 2020 Apr; 59(3):941-951. PubMed ID: 30937580
[TBL] [Abstract][Full Text] [Related]
6. The dietary n6:n3 fatty acid ratio during pregnancy is inversely associated with child neurodevelopment in the EDEN mother-child cohort.
Bernard JY; De Agostini M; Forhan A; de Lauzon-Guillain B; Charles MA; Heude B;
J Nutr; 2013 Sep; 143(9):1481-8. PubMed ID: 23902952
[TBL] [Abstract][Full Text] [Related]
7. The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1/PPARα/GABARAPL1 signalling pathway.
Ramadan NM; Elmasry K; Elsayed HRH; El-Mesery A; Eraky SM
Life Sci; 2022 Dec; 311(Pt A):121145. PubMed ID: 36336129
[TBL] [Abstract][Full Text] [Related]
8. Increased erythrocytes n-3 and n-6 polyunsaturated fatty acids is significantly associated with a lower prevalence of steatosis in patients with type 2 diabetes.
Petit JM; Guiu B; Duvillard L; Jooste V; Brindisi MC; Athias A; Bouillet B; Habchi M; Cottet V; Gambert P; Hillon P; Cercueil JP; Verges B
Clin Nutr; 2012 Aug; 31(4):520-5. PubMed ID: 22209679
[TBL] [Abstract][Full Text] [Related]
9. The Relationship between Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease Measured by Controlled Attenuation Parameter.
Chon YE; Kim KJ; Jung KS; Kim SU; Park JY; Kim do Y; Ahn SH; Chon CY; Chung JB; Park KH; Bae JC; Han KH
Yonsei Med J; 2016 Jul; 57(4):885-92. PubMed ID: 27189281
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Lipogenesis and Brain Fatty Acid Profile in Response to Different Dietary n6/n3 Ratios and DHA/EPA Supplementation in Streptozotocin Treated Rats.
Starčević K; Filipović N; Galan A; Micek V; Gudan Kurilj A; Mašek T
Mol Nutr Food Res; 2018 May; 62(9):e1701007. PubMed ID: 29579359
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for non-alcoholic fatty liver disease-associated hepatic fibrosis in type 2 diabetes patients.
Mansour A; Mohajeri-Tehrani MR; Samadi M; Gerami H; Qorbani M; Bellissimo N; Poustchi H; Hekmatdoost A
Acta Diabetol; 2019 Nov; 56(11):1199-1207. PubMed ID: 31197470
[TBL] [Abstract][Full Text] [Related]
12. Associations of serum n-3 and n-6 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease.
Mäkelä TNK; Tuomainen TP; Hantunen S; Virtanen JK
Am J Clin Nutr; 2022 Sep; 116(3):759-770. PubMed ID: 35648467
[TBL] [Abstract][Full Text] [Related]
13. C-peptide is associated with NAFLD inflammatory and fibrotic progression in type 2 diabetes.
Wang N; Wang Y; Zhang W; Chen Y; Chen X; Wang C; Li Q; Chen C; Jiang B; Lu Y
Diabetes Metab Res Rev; 2020 Feb; 36(2):e3210. PubMed ID: 31351021
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study.
Parker HM; O'Connor HT; Keating SE; Cohn JS; Garg ML; Caterson ID; George J; Johnson NA
Br J Nutr; 2015 Sep; 114(5):780-7. PubMed ID: 26202539
[TBL] [Abstract][Full Text] [Related]
15. Association of grade of non-alcoholic fatty liver disease and glycated albumin to glycated hemoglobin ratio in patients with type 2 diabetes mellitus.
Jung CH; Lee B; Choi DH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
Diabetes Res Clin Pract; 2017 Mar; 125():53-61. PubMed ID: 28167326
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
[TBL] [Abstract][Full Text] [Related]
17. Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids.
van den Berg EH; Flores-Guerrero JL; Gruppen EG; de Borst MH; Wolak-Dinsmore J; Connelly MA; Bakker SJL; Dullaart RPF
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917546
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
[TBL] [Abstract][Full Text] [Related]
19. Serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid is associated with lipid profiles and might protect against non-alcoholic fatty liver disease in Chinese individuals.
Dai J; Yi J; Zhang S; Chen P; Jin H; Yu X; Zhang X
J Diabetes Investig; 2019 May; 10(3):793-800. PubMed ID: 30353682
[TBL] [Abstract][Full Text] [Related]
20. [Serum omega-3 polyunsaturated fatty acid and insulin resistance in type 2 diabetes mellitus and non-alcoholic fatty liver disease].
Zhu QQ; Lou DJ; Si XW; Guan LL; You QY; Yu ZM; Zhang AZ; Li D
Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):305-8. PubMed ID: 20627036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
